You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
HYQVIA is indicated in adults and children 2 years of age and older for:, Replacement therapy in:, Primary Immunodeficiency Disease (PID) and, Symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment., Immunomodulatory therapy in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) as maintenance therapy after stabilisation with intravenous immunoglobulin (IVIG).
These medicine packs are available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
100 mL IG 10% + 5 mL Vorhyaluronidase pack
200 mL IG 10% + 10 mL Vorhyaluronidase pack
25 mL IG 10% + 1.25 mL Vorhyaluronidase pack
300 mL IG 10% + 15 mL Vorhyaluronidase pack
50 mL IG 10% + 2.5 mL Vorhyaluronidase pack
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
HYQVIA is indicated in adults and children 2 years of age and older for:, Replacement therapy in:, Primary Immunodeficiency Disease (PID) and, Symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment., Immunomodulatory therapy in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) as maintenance therapy after stabilisation with intravenous immunoglobulin (IVIG).
These medicine packs are available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
100 mL IG 10% + 5 mL Vorhyaluronidase pack
200 mL IG 10% + 10 mL Vorhyaluronidase pack
25 mL IG 10% + 1.25 mL Vorhyaluronidase pack
300 mL IG 10% + 15 mL Vorhyaluronidase pack
50 mL IG 10% + 2.5 mL Vorhyaluronidase pack
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
HYQVIA is indicated in adults and children 2 years of age and older for:, Replacement therapy in:, Primary Immunodeficiency Disease (PID) and, Symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment., Immunomodulatory therapy in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) as maintenance therapy after stabilisation with intravenous immunoglobulin (IVIG).
These medicine packs are available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
100 mL IG 10% + 5 mL Vorhyaluronidase pack
200 mL IG 10% + 10 mL Vorhyaluronidase pack
25 mL IG 10% + 1.25 mL Vorhyaluronidase pack
300 mL IG 10% + 15 mL Vorhyaluronidase pack
50 mL IG 10% + 2.5 mL Vorhyaluronidase pack
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
HYQVIA is indicated in adults and children 2 years of age and older for:, Replacement therapy in:, Primary Immunodeficiency Disease (PID) and, Symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment., Immunomodulatory therapy in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) as maintenance therapy after stabilisation with intravenous immunoglobulin (IVIG).
These medicine packs are available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
100 mL IG 10% + 5 mL Vorhyaluronidase pack
200 mL IG 10% + 10 mL Vorhyaluronidase pack
25 mL IG 10% + 1.25 mL Vorhyaluronidase pack
300 mL IG 10% + 15 mL Vorhyaluronidase pack
50 mL IG 10% + 2.5 mL Vorhyaluronidase pack
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
HYQVIA is indicated in adults and children 2 years of age and older for:, Replacement therapy in:, Primary Immunodeficiency Disease (PID) and, Symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment., Immunomodulatory therapy in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) as maintenance therapy after stabilisation with intravenous immunoglobulin (IVIG).
These medicine packs are available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
100 mL IG 10% + 5 mL Vorhyaluronidase pack
200 mL IG 10% + 10 mL Vorhyaluronidase pack
25 mL IG 10% + 1.25 mL Vorhyaluronidase pack
300 mL IG 10% + 15 mL Vorhyaluronidase pack
50 mL IG 10% + 2.5 mL Vorhyaluronidase pack
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.
